×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
FSNUY – fresenius se s/adr (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
FSNUY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/26
12:13 pm
fsnuy
Factory in Cranberry Township evacuated due to nitric acid release [CBS News]
Low
Report
Factory in Cranberry Township evacuated due to nitric acid release [CBS News]
11/12
05:56 pm
fsnuy
Fresenius Kabi's Adaptive Nomogram used on Aurora Xi Plasmapheresis System Now Operating Nationwide at BioLife Plasma Centers [Yahoo! Finance]
Medium
Report
Fresenius Kabi's Adaptive Nomogram used on Aurora Xi Plasmapheresis System Now Operating Nationwide at BioLife Plasma Centers [Yahoo! Finance]
11/6
08:49 pm
fsnuy
Fresenius Kabi Issues Voluntary Nationwide Recall of Three Lots of Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL Fill in a 2 mL Vial Due to Out-of-Specification Endotoxin Results in Certain Reserve Samples [Yahoo! Finance]
Low
Report
Fresenius Kabi Issues Voluntary Nationwide Recall of Three Lots of Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL Fill in a 2 mL Vial Due to Out-of-Specification Endotoxin Results in Certain Reserve Samples [Yahoo! Finance]
10/27
03:04 pm
fsnuy
Fresenius SE & Co. (OTCMKTS:FSNUY) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Low
Report
Fresenius SE & Co. (OTCMKTS:FSNUY) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
10/13
07:28 pm
fsnuy
ImpactLife donor receives induction into National Blood Donation Hall of Fame [Yahoo! Finance]
Low
Report
ImpactLife donor receives induction into National Blood Donation Hall of Fame [Yahoo! Finance]
10/9
01:01 am
fsnuy
Fresenius SE & Co. KGaA (ETR:FRE) is largely controlled by institutional shareholders who own 39% of the company [Yahoo! Finance]
Low
Report
Fresenius SE & Co. KGaA (ETR:FRE) is largely controlled by institutional shareholders who own 39% of the company [Yahoo! Finance]
9/25
11:12 am
fsnuy
Fresenius Kabi Receives Two Major Awards for Supply and Service Excellence from Vizient® [Yahoo! Finance]
Low
Report
Fresenius Kabi Receives Two Major Awards for Supply and Service Excellence from Vizient® [Yahoo! Finance]
9/7
08:23 am
fsnuy
Fresenius Kabi and AABB Announce 20th Anniversary of Blood Collectors Week, September 7–14, 2025, Honoring Lifesaving Blood Collection Professionals [Yahoo! Finance]
Low
Report
Fresenius Kabi and AABB Announce 20th Anniversary of Blood Collectors Week, September 7–14, 2025, Honoring Lifesaving Blood Collection Professionals [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/24
FRESENIUS SE &/S (OTCMKTS: FSNUY) was upgraded by analysts at Sanford C. Bernstein from a "market perform" rating to an "outperform" rating.
14.1%
4/7 FRESENIUS SE &/S (OTCMKTS: FSNUY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 2.8%
5/7 FRESENIUS SE &/S (OTCMKTS: FSNUY) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 2.3%
4/23 FRESENIUS SE &/S (OTCMKTS: FSNUY) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 1.2%
12/11 FRESENIUS SE &/S (OTCMKTS: FSNUY) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 1.1%
11/5 Things are getting nasty in the 7th Circuit’s big M&A shareholder class action case [Reuters] 0.9%
4/3 Italy looks to safeguard biomedical valley leading fight against COVID-19 [Reuters (UK)] 0.8%
11/6 Fresenius SE & Co. KGaA to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on 13 November 2019 0.4%
4/7 FRESENIUS SE &/S (OTCMKTS: FSNUY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 2.8%
5/7 FRESENIUS SE &/S (OTCMKTS: FSNUY) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 2.3%
4/23 FRESENIUS SE &/S (OTCMKTS: FSNUY) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 1.2%
12/11 FRESENIUS SE &/S (OTCMKTS: FSNUY) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 1.1%
11/5 Things are getting nasty in the 7th Circuit’s big M&A shareholder class action case [Reuters] 0.9%
4/3 Italy looks to safeguard biomedical valley leading fight against COVID-19 [Reuters (UK)] 0.8%
11/6 Fresenius SE & Co. KGaA to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on 13 November 2019 0.4%
TOP News Decliners
4/30
FRESENIUS SE &/S (OTCMKTS: FSNUY) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.
-2.6%
2/27 FRESENIUS SE &/S (OTCMKTS: FSNUY) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -2.5%
4/23 FRESENIUS SE &/S (OTCMKTS: FSNUY) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. -2.1%
1/24 FRESENIUS SE &/S (OTCMKTS: FSNUY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -2.0%
3/9 FRESENIUS SE &/S (OTCMKTS: FSNUY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -1.9%
12/17 FRESENIUS SE &/S (OTCMKTS: FSNUY) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -1.7%
6/5 New paper documents mootness fee phenomenon in M&A cases, proposes solution [Reuters] -1.2%
4/27 FRESENIUS SE &/S (OTCMKTS: FSNUY) had its "equal weight" rating re-affirmed by analysts at Barclays PLC. -0.6%
2/17 FRESENIUS SE &/S (OTCMKTS: FSNUY) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -0.5%
4/3 Italy looks to safeguard biomedical valley leading fight against COVID-19 [Reuters] -0.3%
2/27 FRESENIUS SE &/S (OTCMKTS: FSNUY) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -2.5%
4/23 FRESENIUS SE &/S (OTCMKTS: FSNUY) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. -2.1%
1/24 FRESENIUS SE &/S (OTCMKTS: FSNUY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -2.0%
3/9 FRESENIUS SE &/S (OTCMKTS: FSNUY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -1.9%
12/17 FRESENIUS SE &/S (OTCMKTS: FSNUY) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -1.7%
6/5 New paper documents mootness fee phenomenon in M&A cases, proposes solution [Reuters] -1.2%
4/27 FRESENIUS SE &/S (OTCMKTS: FSNUY) had its "equal weight" rating re-affirmed by analysts at Barclays PLC. -0.6%
2/17 FRESENIUS SE &/S (OTCMKTS: FSNUY) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -0.5%
4/3 Italy looks to safeguard biomedical valley leading fight against COVID-19 [Reuters] -0.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: